Simulations Plus partners with global pharma company on AI-enabled QSP modeling using Turin
SLP•Simulations Plus entered a funded partnership with a global pharmaceutical company to deploy its Turin AI engine in an active drug program. The collaboration aims to shorten QSP model timelines and may expand to additional therapeutic programs.
1. Turin deployment
The pharma partner will run Simulations Plus’ Turin AI engine in a hosted environment, with support from Simulations Plus scientists during model evaluation. The collaboration aims to scale exploration of mechanistic model structures, cut QSP model build and evaluation timelines, and support broader use of QSP in model-informed drug development, with plans to expand into additional therapeutic programs.
